CLOV241220P3500
- 0.31
- -0.03-8.82%
Clover Health Newsroom
Clover Health Investments Analyst Ratings
Craig-Hallum Initiates Clover Health(CLOV.US) With Buy Rating, Announces Target Price $6
Clover Health Initiated With a Buy at Craig-Hallum
4-star Upgrade To Power Clover Health's (CLOV) Comeback
We Think Clover Health Investments (NASDAQ:CLOV) Can Afford To Drive Business Growth
(CLOV) - Analyzing Clover Health Investments's Short Interest
Here's Why Clover Health Investments (CLOV) Could Be Great Choice for a Bottom Fisher
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health
Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs
Health Insurers Spike as Trump Picks Dr. Oz to Head Medicare
Razorleaf Corporation Unveils the Next Generation of CLOVER: The Advanced Digital Thread Integration Platform
Artificial Intelligence (AI) Reshaping Healthcare Industry With Unimaginable Potential
Down -25.82% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround
Medicare to Adjust Disputed Star Rating Measure: Bloomberg News
Bears Are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Raises Target Price to $4.2
Clover Health | 10-Q: Q3 2024 Earnings Report
Earnings Beat: Clover Health Investments, Corp. (NASDAQ:CLOV) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Clover Health Investments: Strong EBITDA Performance Amid Rising Medical Costs and Revenue Challenges Justifies Hold Rating
CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised